For the quarter ended March 31 total revenue was $7.9 million, down from $8.5 million in the same period a year ago and missed the Street projection of $8.98 million, according to CapIQ.
Price: 1.23, Change: -0.28, Percent Change: -18.76
|Twist Bioscience, Pandion Expand Collaboration on An...|
|Asian ADRs Move Higher in Wednesday Trading|
|Avenue Therapeutics Submits New Drug Application to ...|
|Analyst Actions: Wells Fargo Downgrades Acadia Healt...|
|Analyst Actions: Citigroup Upgrades TechnipFMC to Bu...|